(Q34534314)
Statements
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group (English)
M Martin
A Villar
A Sole-Calvo
R Gonzalez
B Massuti
J Lizon
A Carrato
A Casado
M T Candel
J Albanell
J Aranda
B Munarriz
J Campbell
GEICAM Group (Spanish Breast Cancer Research Group), Spain